|
|
9560 SW Nimbus Ave.
Beaverton, OR 97008 USA
phone:503.624.9830
fax:503.639.0846
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.acrymed.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Technologies using Ionic Silver for Wound Care and Infection Control |
|
| Management |
| Jack D. McMaken, President; Bruce L. Gibbins, Ph.D, Chief Technical Officer; John A. Calhoun, Chief Financial Officer;
David D. Rardin, VP of Marketing & Business Development |
| |
|
|
| |
|
| Keywords |
| woundwound, woundcare |
|
|
|
| Description |
|
AcryMed specializes in the development of advanced wound care and infection control technologies using antimicrobial ionic silver. |
|
| Products / Services |
Acrymed's proprietary SilvaSorb products, including the SilvaSorb Gel, Cavity Dressing, and Site Dressing, are the first to incorporate the antimicrobial properties of ionic silver. The SilvaSorb Gel is applied topically. SilvaSorb dressings also employ AcryMed's patented MicroLattice Technology and release ionic silver in a stabilized, controlled-release formulation to provide a seven-day antimicrobial barrier. The Cavity Dressing is designed to control heavy drainage and fill wound cavities, while the Site Dressing is intended for use around sites of indwelling line insertion or percutaneous entry. The company has also developed Flexi-Gel Wound Dressings and Strands, which also leverage AcryMed's MicroLattice Technology to provide for optimal moisture at the wound site. The Wound Dressings are indicated for exudate absorption and for the management of partial to full thickness wounds.
|
|
| Technology / Differentiation |
| AcryMed has harnessed the advantages of nanotechnology with the broad-spectrum antimicrobial activity of ionic silver in the development of SilvaGard, an proprietary engineered surface treatment for medical devices. SilvaGard is designed to improve the efficacy of indwelling and implantable medical devices, while reducing the risk of deadly medical device-related infections. Consequently, SilvaGard technology renders medical device materials impervious to infection-causing biofilms (well-organized aggregations of microorganisms). |
|
| Market / Customers |
Bacterial infections strike 2 million hospital patients each year; with 90,000 of these patients ultimately dying from this cause. Target customers include developers and distributors of urinary catheters, the most common breeding grounds for hospital infections. Nano-scale silver may soon be applied to permanently implanted devices, such as silicone breast implants, artificial joints (hips and knees) and pacemakers.
|
|
| Status |
| Acrymed was acquired by I Flow in February 2008. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
